DMK PHARMACEUTICALS CORPORATION: cash_and_equivalents
| Value | {"amount": 6855355, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2021-03-31) |
| Status | superseded |
| Entity | DMK PHARMACEUTICALS CORPORATION |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:54:25.189173+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/40f5e4f8-53ab-4bb0-9e0c-55eee69f56e9
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001387131-21-011421 · Open the official SEC filing →Retrieved: 2026-08-19T08:54:25.189173+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000887247/cash-and-equivalents/2021-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/40f5e4f8-53ab-4bb0-9e0c-55eee69f56e9
History
- supersedes {"amount": 57923201, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} (evidence 0001387131-21-011411)